NDARC has been invited to undertake research in partnership with NSW Aboriginal drug and alcohol Residential Rehabilitation Services. This research is unique in being embedded into the routine delivery of their services.
Substance use among pregnant women is a significant public health issue. A range of adverse effects have been noted including increased risk of miscarriage and still birth, reduction in fetal growth, birth defects, developmental delay, growth retardation and neurological abnormalities.
Substance use amongst adolescents (those in the age group of 10-19) is an important public health issue in many countries of the region.
The overarching objective of this project is to produce as comprehensive as possible an estimate of the costs of methamphetamine use to Australian society. The intention is also to develop an approach that could be applied in a consistent manner to other drugs in the future.
Compulsive hoarding is a debilitating disorder. Little is known of the substance use of hoarders, or the circumstances in which they die.
This study aimed to examine the feasibility of agonist maintenance treatment for the major psychoactive drug classes: opioids, nicotine, benzodiazepines, cannabis, psychostimulants and alcohol.
This project forms part of a broader DPMP interest in studying policy-making in Australia. Drug policy is influenced by the research evidence but also by politics, lobby groups, public opinion, and various windows of opportunity.
In this study, we will undertake detailed analyses of the largest cross-national epidemiologic study of mental and substance use disorders ever conducted. The WHO World Mental Health Survey (WMHS) initiative is a massive, unique endeavour.
The Australian government expends an estimated $1.7 billion on responding to illicit drugs every year, with policing comprising 64% of this expenditure. One core assumption underpinning this investment is that police can deter, discourage or prevent drug offending.
Drug use can lead to significant financial, psychological, physical health and social consequences for family members. Despite this, previous economic assessments of drug use interventions have not included the costs and benefits to family members of treatment for the drug user.